Clinical Trials at Seattle Children's Hospital
As of August 2026, 164 paid clinical trials are recruiting at Seattle Children's Hospital, located at 4800 SAND POINT WAY NE, 818-RC, SEATTLE, WA 98105-3901, phone (206) 987-2000 in Seattle, Washington. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Seattle
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
166 clinical trials at Seattle Children's Hospital
·Clear filters·A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
A Study to Assess Growth in Children With Idiopathic Short Stature
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
MEASuRE: Metreleptin Effectiveness And Safety Registry
SPEARHEAD-3 Pediatric Study
Study of Olutasidenib and Temozolomide in HGG
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Minima Stent System Post- Approval Study (PAS)
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
Mucopolysaccharidosis VII Disease Monitoring Program
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
Common conditions studied in Seattle
- Acute Myeloid Leukemia (34 active studies)
- Breast Cancer (20 active studies)
- Colorectal Cancer (19 active studies)
- Ovarian Cancer (16 active studies)
- Multiple Myeloma (15 active studies)
- Prostate Cancer (14 active studies)
Leading research sponsors in Seattle
- University of Washington
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
- Seattle Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Seattle?
There are approximately 1,282 recruiting clinical trials in Seattle, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Seattle pay participants?
Most recruiting trials in Seattle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Seattle?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Seattle?
The most common conditions under active study in Seattle include Acute Myeloid Leukemia (34), Breast Cancer (20), Colorectal Cancer (19), Ovarian Cancer (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Seattle?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Seattle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Seattle?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Seattle?
Recruiting research sites in Seattle include Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Seattle right now?
The largest active categories in Seattle are Cancer & tumors (493), Neurology & pain (64), Diabetes & metabolic (60). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Seattle Children's Hospital?
Seattle Children's Hospital is located at 4800 SAND POINT WAY NE, 818-RC, SEATTLE, WA 98105-3901. Use the Google Maps link in the intro above to get directions.
How do I contact Seattle Children's Hospital?
You can reach Seattle Children's Hospital by phone at (206) 987-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.